Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia

Leukemia

Volumn 13, Issue 7, 1999, Pages 999-1008

  Corsetti, M T ^a   Lerma, E ^a   Dejana, A ^a   Basta, P ^a   Ferrara, R ^a   Benvenuto, F ^a   Vassallo, F ^a   Abate, M ^a   Piaggio, G ^a   Parodi, C ^a   Sessarego, M ^a   Li Pira, G ^b   Manca, F ^b   Carella, A A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Advanced Biotechnology Center   (Italy)

Author keywords

Autologous stem cell transplant; BCR ABL; Chronic myelogenous leukemia; Peripheral blood progenitor cells; Quantitative competitive RT PCR

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; MESSENGER RNA; RNA;

ADULT; ARTICLE; AUTOGRAFT; CELL SELECTION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; METAPHASE; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 0032814042     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401457     Document Type: Article

References (31)

1. Rowley J. A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 1973; 243: 290-293.
2. Shtivelman E, Lifshitz B, Gale R, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 1985; 315: 550-554.
3. Daley G, Van Etten R, Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824-830.
4. Clift R, Appelbaum F, Thomas E. Bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 2752-2753.
5. McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan N. Unrelated marrow transplantation fro chronic myelogenous leukemia. Blood 1993; 81: 543-550.
6. Ozer H, George S, Schiffer C, Rao K, Rao P, Wuster-Hill D, Arther D, Powell B, Gottlieb A, Peterson B, Rai K, Testa J, LeBeau M, Tantravahi R, Bloomfield C. Prolonged subcutaneous administration of recombinant alfa-2b interferon in patients with previously untreated Philadelphia-chromosome positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival. Cancer and Leukemia Group B Study 8583. Blood 1993; 82: 2975-2984.
7. Allan N, Richards S, Shepard P. UK Medical Research Council randomized multicenter trial on interferon-a in chronic myelogenous leukemia - improved survival irrespective of cytogenetic response. Lancet 1995; 345: 1392-1397.
8. Helman R, Group GCS. Randomized comparison of interferon-a with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994; 84: 4064-4077.
9. The Italian Cooperative Study Group on Chronic Myelogenous Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myelogenous leukemia. New Engl J Med 1994; 330: 820-825.
10. Bhatia R, Verfaille C, Miller J, McGlave P. Autologous transplantation therapy for chronic myelogenous leukemia. Blood 1997; 89: 2623-2634.
11. Coulombel L, Kalousek D, Eaves C, Gupta C, Eaves A. Long-term marrow culture reveals chromosomally normal hemopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New Engl J Med 1983; 306: 1493-1498.
12. Carella A, Podesta M, Frassoni F, Raffo M, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C, Ferrero R, Benvenuto F, Figari O, Carlier P, Levcasis G, Valbonesi M, Vitale V, Giordano D, Pierluigi D, Nati S, Guerracio A, Rosso C, Saglio G. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-271.
13. Carella A, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podesta M, Celesti L, Chimirri F, Abate M, Vassallo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti A, Van Den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelpia-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.
14. Lion T, Gaiger A, Henn T, North E, Haas O, Geissler K, Gadner H. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia 1995; 9: 1353-1360.
15. Hochhaus A, Lin F, Reiter A, Skladny H, Mason P, van Rhee F, Shepherd P, Allan N, Hehlmann R, Goldman J, Cross N. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549-1555.
16. Lion T, Henn T, Gaiger A, Kalhs P, Gadner H. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet 1993; 341: 275-276.
17. Cross N, Feng L, Chase A, Bungey J, Hughes T, Goldman J. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1936.
18. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
19. Saglio G, Pane F, Gottard IE, Frigeri F, Buonaiuto M, Guerrasio A, de Micheli D, Parziale A, Fornaci M, Martinelli G, Salvatore F. Consistent amount of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 1996; 87: 1075-1080.
20. Daugherty B, DeMartino J, Law M, Kawka D, Singer I, Mark G. Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins. Nucleic Acids Res 1991; 19: 2471-2476.
21. Melo J. The molecular biology of chronic myeloid leukaemia. Leukemia 1996; 10: 751-756.
22. Carella A, Lerma E, Corsetti MT, Dejana A, Celesti L, Vassallo F, Abate M, Soracco M, Benvenuto F, Figari O, Podestà M, Piaggio C, Sessarego M, Parodi C, Rubagotti A. Autografting with Philadelphia chromosome negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood 1999; 93: 1534-1539.
23. Udomsakdi C, Eaves C, Swolin B, Reid D, Barnett M, Eaves A. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 1992; 89: 6192-6196.
24. Petzer A, Eaves C, Lansdorp P, Ponchio L, Barnett M, Eaves A. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 1996; 88: 2162-2171.
25. Finney R, McDonald A, Baikie A, Douglas A. Chronic granulocytic leukemia with Ph1 negative cells in cone marrow and a ten year after busulphan-induced hypoplasia. Br J Haematol 1972; 23: 283-288.
26. Cunningham I, Gee T, Dowling M, Chaganti R, Bailey R, Hopfan S, Bowden L, Turnbull A, Knapper W, Clarkson B. Results of treatment of Ph1 positive chronic myeloid leukemia with an intensive treatment regimen (L-5 protocol). Blood 1979; 53: 375-396.
27. Bergamaschi C, Podesta M, Frassoni F, Rosti V, Carella A, Saglio G, Cazzola M. Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells. Br J Haematol 1994; 87: 867-870.
28. Podesta M, Piaggio G, Sessarego M, Pitto A, Benvenuto F, Vassallo F, Fugazza G, Carella A, Frassoni F. Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease. Br J Haematol 1997; 97: 94-98.
29. Chalmers E, Franklin I, Kelsey S, Newland A, Clark R, Sproul A, Crotty G, McCann S, Fielding A, Goldstone A, Hepplestone A, Watson W, Sharp R, Tansey P. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cells. Br J Haematol 1997; 96: 627-634.
30. Heinzinger M, Waller C, Rosenstiel A, Scheid S, Burger K, Lange W. Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. Leukemia 1998; 12: 333-339.
31. Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Bussing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML. Bone Marrow Transplant 1998; 21: 1029-1036.